The Science and Realities of Long-Term GLP-1 Use

The Science and Realities of Long-Term GLP-1 Use

Losing weight on a GLP-1 medication can feel like magic until the scale stops moving. For almost everyone on these drugs, there comes a moment when the rapid progress slows, then stalls completely. Is the medication failing? Has your metabolism adapted? Did you do something wrong? For most people, that moment feels like a problem. It isn't. Join Holly and Jim as they unpack one of the most misunderstood parts of the GLP-1 journey: the shift from losing weight to keeping it off. You'll discover why a stalled scale is actually a sign the medication is doing exactly what it's supposed to do, and why "maintenance" is a completely different physiological state than "weight loss." One that comes with its own rules. Along the way, you'll pick up science-backed (and some still-unanswered) guidance on nutrition, muscle, bone health, and motivation for the long haul, plus a clear answer to a question Holly says she gets all the time: Are they against staying on these medications long-term? Discussed on the episode: * Why hitting a plateau on a GLP-1 is good news, not a sign the drug has stopped working. * The blood pressure pill comparison that reframes what people call "drug resistance" * Why nutrition may matter even more, not less, once weight loss stops * Whether you actually need to exercise to keep weight off on a GLP-1 (the honest answer might surprise you) * The bone health risk in younger women that's getting far less attention than muscle loss * Why are dose-tapering and switching strategies being called the "Wild West" of GLP-1 care * A New York Times claim about these medications "rewiring the brain" and what that could mean long after you stop. * How to find motivation once the scale refuses to budge Have a question or a success story? Send it in. Holly and Jim read every one, and they're especially looking for listener stories about navigating weight loss maintenance.

The Hidden Influence of Community and Environment with Christina Economos

What if the biggest obstacle to your health isn't your willpower, it's your zip code? Most of us have been raised to believe that weight and health come down to personal choices: what you eat, how much you move, how disciplined you are. But what if the deck has been stacked against millions of Americans before they ever make a single decision? This week, Holly and Jim sit down with Dr. Christina Economos, Dean of the Friedman School of Nutrition Sciences and Policy at Tufts University, to explore one of the most important  and most overlooked dimensions of the obesity epidemic: the environments we live in. With decades of groundbreaking research behind her, including the landmark Shape Up Somerville study, Dr. Economos makes a compelling case that lasting health change can't happen one person at a time. And with GLP-1 medications reshaping what's possible for individual weight loss, the conversation has never been more urgent. Does community still matter when we have powerful new treatments? Dr. Economos has a clear answer, and it just might change how you see your own role in the bigger picture. Discussed on the episode: * The landmark study that proved community-wide obesity prevention actually works in the real world, and the surprising ripple effect it had beyond the children involved. * Why your zip code may predict your health outcomes nearly as powerfully as your genetics * The hidden forces in your neighborhood that are quietly shaping what you eat and how much you move, often without you realizing it * What a food environment assessment in the Mississippi Delta revealed perfectly captures the challenge millions of Americans face daily * Why fixing schools alone won't fix childhood obesity, and what actually needs to happen instead * The honest answer to how much of the obesity epidemic is biology versus environment (hint: it's not a clean split) * The key ingredients, Dr. Economos says, every successful community health intervention must have, and the #1 mistake researchers keep making * How GLP-1 medications and community health are more connected than you might think * What "spark plugs" are, why every successful health movement has had them, and whether you could be one * Real U.S. communities that are getting this right and what they're actually doing differently * Practical steps anyone can take right now, even if your environment is working against you

The Rise and Fall of Popular Diets Over 100 Years

If you've spent years hopping from one diet to the next: low fat, then low carb, then keto, then intermittent fasting, you're not alone, and you're not failing. The truth is, the diet world has been cycling through the same promises, the same villains, and the same disappointments for nearly a hundred years. And most of us never stop to ask why. Join Holly and Jim as they do something they've never done before on the show: step back and take a decade-by-decade look at almost 100 years of dieting history. From the 1930s to the GLP-1 era of today, they trace how we went from counting calories to carnivore diets  and what it all actually taught us (or didn't). This one is equal parts fascinating, a little humbling, and surprisingly fun. Whether you're a diet history nerd or just someone who's tired of starting over, this episode will change the way you think about every diet you've ever tried. Discussed on the episode: * The three-category system Holly and Jim use to classify every diet, and why one category might describe your current eating plan * The diet from the 1930s that your favorite wellness influencer is basically still selling today * Why the decade that got everyone obsessed with fat-free foods may have actually made obesity worse * The weight loss medication that came before GLP-1s, and the dramatic reason it was pulled from the market * Which diets from the last 100 years actually have the science to back them up * The rapid-fire verdict: best diet, biggest mistake, and most underrated program of the century * What GLP-1 medications are changing about the way we think about diets, and why Holly has one big worry about where this is all heading * Jim's closing thought that reframes everything you think you know about why diets succeed or fail

Why Dietitians Matter More Than Ever with Maha Tahiri

Millions of people are now taking GLP-1 medications and losing weight, but is eating less the same as eating better? The answer, according to today's guest, is a resounding no. And almost nobody in medicine, food, or public health is talking seriously about what happens when appetite disappears, but nutritional needs don't. Join Holly and Jim as they sit down with Dr. Maha Tahiri, a nutrition scientist, food industry strategist, and founder of Nutrition Sustainability Strategies, for one of the most eye-opening conversations in the GLP-1 era. Maha has spent decades at the crossroads of nutrition science, public health, and food innovation, and she's now helping companies around the world rethink what it means to nourish a consumer who's eating dramatically less. Her new company, S2B, is building a strategy for the GLP-1 era and beyond, and she's asking the questions that urgently need answers. This episode will change how you think about GLP-1 medications, food, and what it truly means to be well-nourished. Discussed on the episode: * Why eating less on GLP-1s does NOT mean you're eating better and the nutritional crisis hiding in plain sight * The alarming statistic about how many GLP-1 users are falling short on fiber, protein, and key micronutrients * Why Maha calls what's happening to GLP-1 users "medically induced malnutrition" and why that phrase should get your attention * The one behavior Holly says is now more important on GLP-1s than ever before (not what most people expect) * Why fiber deserves its own strategy and why lumping it in with protein is a mistake. * The three phases of GLP-1 use that should shape everything you eat * What a strange debate in Botswana had to do with Maha's entire career pivot * The unexpected food category that's actually thriving because of GLP-1 users * Why the food industry may owe pharma a thank-you and what it needs to do with its second chance * The role AI is now playing in nutrition advice, and why Maha thinks that's actually good news * Maha's rapid-fire picks: the most underrated nutrient, the most overrated trend, and the one food she'd put in every kitchen.

What Comes After GLP-1 Success with Ken Fujioka

What if the medications changing everything about obesity treatment are also creating problems nobody saw coming? We’re living through a genuine before-and-after moment in obesity medicine. Drugs that once seemed like science fiction are now producing 20, even 25% weight loss in real patients. But the questions piling up are just as staggering as the results: What happens to your muscle? Your bone? Your sense of self? And what happens when the medication stops? Holly and Jim sit down with Dr. Ken Fujioka, an endocrinologist, director of the Nutrition and Metabolic Research Center at Scripps Clinic, and one of the very first physicians to build an entire career around treating obesity, long before it was popular or even respected. He’s run over 100 clinical trials, treated thousands of patients a month, and watched this field go from Fen-phen clinics to GLP-1 breakthroughs. If anyone has the perspective to separate the genuine revolution from the hype, it’s Ken. This episode is a masterclass in what actually happens in the exam room, not in a clinical trial, not in a headline, but with real patients facing real tradeoffs. Ken is refreshingly practical, deeply experienced, and not trying to win any argument. He’s just trying to help people build healthier lives in the middle of one of the fastest-moving moments medicine has ever seen. Discussed on the episode: * Why a shortage revealed a danger nobody was talking about, and why emergency rooms are still seeing the consequences * The patients who are actually reaching their goal weight for the first time ever (and what that creates as the new problem to solve) * What Ken tells patients who want to reduce or stop their medication, and the pattern he keeps seeing a few months later. * The one group of patients he’s seen keeps the weight off without staying on the drugs, and what might explain it. * Why losing weight faster is one of the biggest mistakes being made right now, and what the bariatric surgery literature has been telling us for years * How Ken decides which medication to prescribe and why insurance coverage is always the first question * The muscle loss conversation: why it’s like pulling teeth, and the one thing he’s considering making non-negotiable * What the next generation of obesity drugs looks like, and the hormone that once seemed like a crazy idea that now has Ken most excited * His rapid-fire answers: the most underrated obesity treatment tool, the biggest mistake clinicians make, and the one thing patients should protect above everything else * The single thing Ken hopes every listener walks away remembering